Canterbury Park GAAP EPS of $0.18, revenue of $19.08M (NASDAQ:CPHC)

Canterbury Park reported Q3 GAAP EPS of $0.18 and revenue of $19.08M, up 4.1% year-over-year, according to the company's press release.

Original reporting
Published Nov 10, 2026, 10:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 10:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CPHC
Neutral
medium confidence
Mentioned
$CPHC
Relevance
7/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$CPHCNeutralMed
01

Why it matters

The earnings numbers are new information but the company’s small market cap limits the potential market impact.

02

Market read

Fresh earnings data for a micro‑cap; likely limited price reaction.

03

What to watch

No forward guidance was provided, leaving future performance uncertain.

Relevance 7/10Novelty 7/10Timing: after-hours release

Background

Canterbury Park Holding Corp (NASDAQ:CPHC) reported its Q3 GAAP earnings and revenue.

Company-level read

Ticker impact

$CPHCNeutralMedium confidence
Context

Q3 GAAP EPS of $0.18 and revenue of $19.08M were disclosed for the first time.

Expected impact

potential modest move as market digests earnings

Evidence & confidence

New earnings numbers are fresh but the scale is small; no guidance or surprise element was provided.

Market effects

Limited impact on the broader gaming/entertainment sector.

Minimal effect on U.S. markets due to micro‑cap size.

None

Counterpoint

The earnings beat is modest; investors may view the results as insufficient for upside.

Key entities

  • Canterbury Park Holding Corp

    Micro‑cap gaming and entertainment operator.

Related articles

$RSKDHighAI 8/10

DA Davidson raises Riskified stock price target on strong results

DA Davidson raised its price target for Riskified (NYSE: RSKD) to $12.00 from $9.00, citing strong Q3 results. Revenue grew 41% YoY to $115.2M, beating estimates. The company raised 2026 revenue guidance and lifted gross profit growth outlook. Truist Securities also raised its target to $14.00. RSKD stock surged 25% post-results, up 126% over six months.

$EYEMed

National Vision Q3 2026 slides: margins expand amid traffic headwinds

National Vision Holdings (EYE) reported Q3 2026 net revenue of $510.5M, up 4.8% YoY, with adjusted operating income of $37.1M and EPS of $0.30. Margins expanded despite traffic declines, driven by higher-value customers and premium products. The company opened 8 new stores and closed 4, ending with 1,285 locations. Shares rose 1.55% to $18.37 post-earnings. Management focuses on managed care and premium products for future growth.

$TWSTMedAI 8/10

Full-Year Revenue Guidance and Strong Quarter Drove Twist Bioscience Corporation (TWST) Higher in Q3

Artisan Partners' Q3 2026 investor letter highlights Twist Bioscience (TWST) as a top performer, citing strong revenue growth and raised full-year guidance. The biotech company specializes in synthetic DNA products, with shares up 310% over the past year despite a recent pullback. Artisan notes AI-driven demand and management's EBITDA breakeven target as key growth drivers.